Showing posts with label STICH. Show all posts
Showing posts with label STICH. Show all posts

Tuesday, August 23, 2011

HCFI Update: Opt for medical treatment for heart blockages with low left heart functions

For most patients with systolic left heart pumping function (LVEF) of 35 percent or less and coronary heart blockages amenable to bypass surgery one should first initiate optimal medical therapy alone rather than medical therapy plus bypass surgery, said Padmashri and Dr B C Roy National Awardee Dr K K Aggarwal President Heart Care Foundation of India and MTNL Perfect Health Mela.

Earlier view had been that compared with medical therapy, surgical bypass of viable heart muscle improves both survival and left heart function. This view was based on the fact that up to 50 percent of patients with left heart pumping dysfunction due to coronary heart blockages have a significant amount of viable heart muscles.

The results of Surgical Treatment for Ischemic Heart Failure (STICH), a randomized trial have shown that compared with optimal medical therapy alone, optimal medical therapy plus bypass surgery resulted in no significant improvement in the primary outcome of all-cause mortality at a median follow-up of 56.

The current recommendation that one should initiate optimal medical therapy alone rather than optimal medical therapy plus bypass surgery is based upon the significant morbidity associated with bypass surgery. Bypass surgery, however, is preferred by patients with ongoing anginal symptoms despite optimal medical therapy.

Tuesday, July 19, 2011

Dr KK Answers: What to opt: Medical or surgical revascularization in patients with coronary heart blockages with reduced left ventricular function (heart pumping)?

Up to 50% of patients with low pumping function of the heart due to coronary heart blockages have a significant amount of viable hibernating heart muscles. Many earlier studies have shown that, when compared to drugs, surgical revascularization of hibernating heart muscles improves both survival and heart function. The Surgical Treatment for Ischemic Heart Failure (STICH) trial was the first randomized trial to compare the combination of optimal medical therapy and surgical revascularization with optimal medical therapy alone in patients with stable heart disease, heart pumping function 0f 35 percent or less, and coronary artery blockages amenable to coronary artery bypass graft (CABG) surgery.

Compared to optimal medical therapy alone, optimal medical therapy plus CABG surgery resulted in no significant improvement in all-cause mortality at a median follow-up of 56 months (36 versus 41 percent with medical therapy alone). 

In all patients with heart pumping function of 35 percent or less and coronary artery blockages amenable to CABG surgery, one should opt for an initial course of optimal medical therapy alone rather than optimal medical therapy plus CABG surgery. This is based on the significant morbidity associated with CABG surgery. 

However one should opt for CABG surgery in presence of ongoing anginal symptoms despite optimal medical therapy.
(N Engl J Med 2011; 364:1607)